Covid-19: Herd Immunity Can’t Be Strategic Choice Or Option In India, Says Health Ministry
Health workers dispose of their personal protective equipment (PPE) after conducting rapid-antigen methodology Covid-19 tests from a testing vehicle at a healthcare center in New Delhi. (Photographer: T. Narayan/Bloomberg)

Covid-19: Herd Immunity Can’t Be Strategic Choice Or Option In India, Says Health Ministry

Bookmark

Given the size of India's population, herd immunity "cannot be a strategic choice or option", the health ministry said on Thursday as it urged people to follow Covid-appropriate behaviour till a vaccine is developed.

At a press briefing, when asked whether India was approaching herd immunity against the coronavirus infection, Officer on Special Duty in the Health Ministry Rajesh Bhushan replied that herd immunity is a kind of indirect protection from an infectious disease like Covid-19.

It happens only when a population becomes immune either through vaccination or immunity is developed through a previous infection, he said.

"In a country with the size of the population like India, herd immunity cannot be a strategic choice or option. It can only be an outcome, and that too at a very high cost as it means lakhs of people would have to be infected, get hospitalised and many would die in the process," Bhushan said.

He said herd immunity can be achieved through immunisation but that is in the future.

"Are we approaching herd immunity? The health ministry believes it still far away and in the future. For now, we have to follow Covid-appropriate behaviour like wearing masks, avoiding gatherings, following hand hygiene and maintaining 'do gaz ki doori (maintaining distance of two yards)," he said.

Till a vaccine comes up, following Covid-appropriate behaviour is the social vaccine against the disease.
Rajesh Bhushan, Officer On Special Duty, Health Ministry

Also read: Herd Immunity May Be Developing in Mumbai’s Poorest Areas

The officer also said phase 1 and 2 human clinical trials of two indigenously developed Covid-19 vaccine candidates have started.

Bhushan also said the government has so far received 131 claims under the Rs 50 lakh Covid-19 insurance scheme for healthcare providers and payments have already been made in 20 cases.

"Under the scheme, we have received 131 claims. The claims are a bit slow in coming as the families are initially in a state of shock and therefore it takes time to sign and fill up the necessary paperwork," he said.

"Out of these 131 claims, in 20 cases payments have already been made. In Sixty-four cases payment has been processed and would be made in the coming few days while 47 cases are with different state governments," he said.

About the spread of coronavirus infection in the country, Bhushan said Maharashtra, Delhi and Telangana have reported the maximum number of cases.

Due to enhanced testing infrastructure, on an average 4,68,263 Covid-19 tests have been conducted daily from July 26 to 30. The recovery rate among COVID-19 patients too has increased from 7.85% in April to 64.44% on Thursday, the officer said.

Also read: Coronavirus India Updates: India Adds Over 50,000 Fresh Cases Amid Further Relaxations

"Recoveries are now 1.9 times the number of active coronavirus cases," he noted.

Bhushan further said that 21 states and Union Territories have case positivity rate less than 10%, while in four it is less than five per cent. The COVID-19 positivity rate in Rajasthan is 3.5%, Punjab 3.9%, Madhya Pradesh 4%, and Jammu and Kashmir 4.7%, he said.

Bhushan also stressed that effective clinical management has led to a decline in Covid-19 case fatality rate from 3.33 % on June 18 to 2.21 % on July 30.

BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.